Bio-FD&C Co Ltd
KOSDAQ:251120
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
12 170
17 740
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Bio-FD&C Co Ltd
Total Receivables
Bio-FD&C Co Ltd
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
B
|
Bio-FD&C Co Ltd
KOSDAQ:251120
|
Total Receivables
â‚©3B
|
CAGR 3-Years
45%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Celltrion Inc
KRX:068270
|
Total Receivables
â‚©975.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
||
SK Bioscience Co Ltd
KRX:302440
|
Total Receivables
â‚©22.3B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
||
H
|
Hugel Inc
KOSDAQ:145020
|
Total Receivables
â‚©46.4B
|
CAGR 3-Years
18%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Total Receivables
â‚©51.8B
|
CAGR 3-Years
22%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
Alteogen Inc
KOSDAQ:196170
|
Total Receivables
â‚©7.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
Bio-FD&C Co Ltd
Glance View
Bio-FD&C Co., Ltd. engages in the development of bio and health technologies. The company is headquartered in Incheon, Incheon and currently employs 61 full-time employees. The company went IPO on 2022-02-21. The firm is mainly engaged in the manufacture and sale of soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, acanthopanax koreanum adventitious root culture extract. The firm's products are mainly used as materials for cosmeceuticals, health functional foods and pharmaceuticals.
See Also
What is Bio-FD&C Co Ltd's Total Receivables?
Total Receivables
3B
KRW
Based on the financial report for Dec 31, 2023, Bio-FD&C Co Ltd's Total Receivables amounts to 3B KRW.
What is Bio-FD&C Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
29%
Over the last year, the Total Receivables growth was 32%. The average annual Total Receivables growth rates for Bio-FD&C Co Ltd have been 45% over the past three years , 29% over the past five years .